These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 688701)

  • 1. The effect of adenosine on mitogenesis of ADA-deficient lymphocytes.
    Uberti J; Lightbody JJ; Wolf JW; Anderson JA; Reid RH; Johnson RM
    Clin Immunol Immunopathol; 1978 Aug; 10(4):446-58. PubMed ID: 688701
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential inhibition of adenosine deaminase deficient peripheral blood lymphocytes and lymphoid line cells by deoxyadenosine and adenosine.
    Hirschhorn R; Bajaj S; Borkowsky W; Kowalski A; Hong R; Rubinstein A; Papageorgiou P
    Cell Immunol; 1979 Feb; 42(2):418-23. PubMed ID: 311698
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological and biochemical profiles in response to transfusion therapy in an adenosine deaminase-deficient patient with severe combined immunodeficiency disease.
    Dyminski JW; Daoud A; Lampkin BC; Limouze S; Donofrio J; Coleman MS; Hutton JJ
    Clin Immunol Immunopathol; 1979 Nov; 14(3):307-26. PubMed ID: 498598
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete adenosine deaminase (ADA) deficiency without immunodeficiency, and primary hyperoxaluria, in a 12-year-old boy.
    Perignon JL; Hamet M; Cartier P; Griscelli C
    Adv Exp Med Biol; 1980; 122A():403-8. PubMed ID: 6968500
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency.
    Polmar SH
    Ciba Found Symp; 1978; (68):213-30. PubMed ID: 227649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenine and adenosine metabolism in lymphocytes deficient in adenosine deaminase (ADA) activity.
    Raivio KO; Schwartz AL; Stern RC; Polmar SH
    Adv Exp Med Biol; 1977; 76A():456-62. PubMed ID: 855721
    [No Abstract]   [Full Text] [Related]  

  • 7. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
    Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
    J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
    Simmonds HA; Panayi GS; Corrigall V
    Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine dysfunction in cells from patients with adenosine deaminase deficiency.
    Benke PJ; Dittmar D
    Pediatr Res; 1976 Jul; 10(7):642-6. PubMed ID: 132630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of deoxyribonucleotides as a possible mediator of immunosuppression in hereditary deficiency of adenosine deaminase.
    Bluestein HG; Willis RC; Thompson LF; Matsumoto S; Seegmiller JE
    Trans Assoc Am Physicians; 1978; 91():394-402. PubMed ID: 314193
    [No Abstract]   [Full Text] [Related]  

  • 11. Adenosine deaminase deficiency in combined immunologic deficiency disease.
    Meuwissen HJ; Pickering RJ; Pollara B
    Birth Defects Orig Artic Ser; 1975; 11(1):117-9. PubMed ID: 1148375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe combined immunodeficiency in a child with a healthy adenosine deaminase deficient mother.
    Schmalstieg FC; Mills GC; Tsuda H; Goldman AS
    Pediatr Res; 1983 Dec; 17(12):935-40. PubMed ID: 6606796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine deaminase deficiency and severe combined immunodeficiency disease.
    Thompson LF; Seegmiller JE
    Adv Enzymol Relat Areas Mol Biol; 1980; 51():167-210. PubMed ID: 6255772
    [No Abstract]   [Full Text] [Related]  

  • 14. A lymphoblastoid cell line from an adenosine deaminase deficient patient established by Epstein-Barr virus.
    Tsuchiya S; Narisawa K; Konno T; Tada K
    Tohoku J Exp Med; 1979 Oct; 129(2):105-10. PubMed ID: 227140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological reconstitution after HLA-haploidentical bone marrow transplantation for SCID in an infant with ADA deficiency.
    Lanfranchi A; Nespoli L; Porta F; Martelli MF; Aversa F; Bonetti F; Locatelli F; Gibardi A; Martinetti M; Burgio GR
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():168-70. PubMed ID: 2627620
    [No Abstract]   [Full Text] [Related]  

  • 16. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
    Cowan MJ; Shannon KM; Wara DW; Ammann AJ
    Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase and immunodeficiency.
    Cohen F
    Birth Defects Orig Artic Ser; 1975; 11(1):124-7. PubMed ID: 1148377
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
    Albert D; Bluestein HG; Thompson L; Seegmiller JE
    Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADA and PNP deficiencies: how it all began.
    Giblett ER
    Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo and in vitro effects of thymosin and adenosine deaminase on adenosine-deaminase-deficient lymphocytes.
    Rubinstein A; Hirschhorn R; Sicklick M; Murphy RA
    N Engl J Med; 1979 Feb; 300(8):387-92. PubMed ID: 310515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.